Critical Care and Perioperative Implications of New Diabetic Medications
Leveraging Electronic Medical Records and Preoperative Clinics to Mitigate Risks Associated With SGLT-2 Inhibitors and GLP-1 Agonists in the Perioperative Setting
Disclosure(s): No relevant financial relationship(s) to disclose.
Disclosure(s):
Laura M. Ebbitt, PharmD: No relevant financial relationship(s) to disclose.
This session will focus on mitigation and harm reduction strategies in the perioperative setting to avoid complications associated with SGLT-2 Inhibitors and GLP-1 agonists.
